Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Not yet recruiting 4 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 240 Radiotherapy 216 Gemcitabine 187 Cisplatin 185 Carboplatin 182 Docetaxel 166 Bevacizumab 166 Paclitaxel 144 Rituximab 141 Capecitabine 141 pembrolizumab 139 Oxaliplatin 124 Nivolumab 124 Dexamethasone 122 Fluorouracil 113 fludarabine 103 Radiosurgery 101 Doxorubicin 99 fludarabine phosphate 96 Irinotecan 96 Etoposide 95 Lenalidomide 93 Cytarabine 91 Magnetic Resonance Spectroscopy 90 Radiation 89 Leucovorin 88 Filgrastim 88 Bortezomib 86 Cetuximab 80 Pemetrexed 79

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × inavolisib × Clear all

NCT04849364 2025-05-31

PERSEVERE

Hoosier Cancer Research Network

Phase 2 Terminated

52 enrolled 16 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡